BackTATA Health International Holdings Limited Overview
TATA Health International Holdings Limited

TATA Health International Holdings Limited Return on Equity

Valuation check: 1255.HK's ROE is 91.15%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

91.15%

Return on Equity

91.15%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

TATA Health International Holdings Limited (1255.HK) FAQ

TATA Health International Holdings Limited's return on equity stands at 91.15%. That is above the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

TATA Health International Holdings Limited sits higher the its sector benchmark (11.3%) with a ROE of 91.15%. That is roughly 706.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 91.15% for TATA Health International Holdings Limited means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how TATA Health International Holdings Limited's ROE evolved across reporting periods, while the comparison chart places 1255.HK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.